Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000499652 | SCV000596811 | likely benign | not specified | 2015-10-07 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000651116 | SCV000772966 | benign | Dyskeratosis congenita, autosomal recessive 5; Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 3 | 2025-02-02 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002383971 | SCV002693078 | likely benign | Inborn genetic diseases | 2022-05-02 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Breakthrough Genomics, |
RCV004704027 | SCV005210170 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Natera, |
RCV001272640 | SCV001454879 | benign | Dyskeratosis congenita | 2020-09-16 | no assertion criteria provided | clinical testing |